Mme Docteur SARAH SALOMON-GOEB
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
2
h articles cités ≥ h fois chacun. Un h de 2 = 2 publications avec 2+ citations.
Citations
13
Publications
3
i10-index
1
Thématiques principales
- Spondyloarthritis Studies and Treatments ×2
- Rheumatoid Arthritis Research and Therapies ×1
- Thyroid Disorders and Treatments ×1
- Psoriasis: Treatment and Pathogenesis ×1
- Gout, Hyperuricemia, Uric Acid ×1
Affiliations FR : Centre Hospitalier Universitaire Amiens-Picardie · Clinique Victor Hugo
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
Interest in daily clinical practice of screening for gouty disease in patients with psoriatic arthritis
2024ArticleRheumatology Advances in Practice
Therapeutic Maintenance of Baricitinib and Tofacitinib in Real Life
2020ArticleJournal of Clinical Medicine
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Localisation
Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.
Lieux de consultation
CHU AMIENS SUD
1 Rond point PROFESSEUR CHRISTIAN CABROL, 80054 Amiens
SELARL DU DOCTEUR SARAH SALOMON GOEB
CLINIQUE VICTOR PAUCHET — 2 AVENUE D IRLANDE, 80090 Amiens
Libéral© OpenStreetMap
Tarifs & secteur de conventionnement
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Top publications · les plus citées
- 1Therapeutic Maintenance of Baricitinib and Tofacitinib in Real Life
Journal of clinical medicine · 2020
Lire l'abstract Crossref ↓
Background: Janus kinase inhibitors (JAKis) represent a new alternative to treat rheumatoid arthritis (RA). The objective of this study was to evaluate the effectiveness, tolerance profile, and maintenance of these treatments (tofacitinib and baricitinib) in real life. Methods: All patients in the rheumatology department of Amiens University Hospital treated by JAKis for RA were included from 1 October 2017 to 20 May 2020. Clinical and biological data were provided retrospectively in this observational and single-center study. We aimed to study the JAKi maintenance rate at 12 months and their clinical and biological safety profiles. Results: Fifty-five patients were included. Drug maintenance at 12 months was 67.6%. Factors associated with poorer maintenance were a higher Charlson comorbidity index (HR 1.311 (1.089–1.579); p = 0.0042), a higher age (HR 1.055 (1.015–1.096); p = 0.0067), and corticosteroids therapy at initiation (HR 2.722 (1.006–7.365); p = 0.0487). The clinical and biological safety profile was generally good. Conclusions: Our study found that a higher Charlson index, age, and corticosteroids appeared to be associated with the earlier discontinuation of treatment. JAKis had a response and tolerance profile in real life at least equivalent to that of biological disease-modifying antirheumatic drugs (bDMARDs).
- 2Lumbar zygapophyseal joints injections under ultrasound guidance an alternative to fluoroscopy guidance in the management of low back pain
Scientific reports · 2022
Lire l'abstract Crossref ↓
AbstractUltrasound-guided injections are an alternative to evaluate in the management of low back pain associated with osteoarthritis of the lumbar facet joints: it eliminates the risk of ionizing radiation for both the patient and the practitioner. This study aims to compare the short-term clinical efficacy of lumbar facet joints injections between ultrasound-guided injections and fluoroscopy-guided injections. Observational, retrospective, single-center study. Patients received one or two lumbar zygapophyseal joints injections under fluoroscopy or ultrasound and a follow-up consultation at one month. Data from 54 patients was collected. The median of the evolution of VAS at one month was − 30 mm [−50.0; −20.0] in the ultrasound group and – 29.5 mm [−47.0; −15.0] (p < 0.001) in the fluoroscopy group with no statistically significant difference between the two groups (p = 0.835). There were no injection-related complications in either group during the follow-up. The percentage of patients who stopped NSAIDs was not statistically significant between the two groups (p = 1.00). Injections of corticosteroids of lumbar facet joints under ultrasound guidance significantly reduced pain after one month, with no difference found between the two techniques. Ultrasound-guided injections are reliable, accessible and a safe alternative that should be preferred over those under fluoroscopy.
- 3Interest in daily clinical practice of screening for gouty disease in patients with psoriatic arthritis
Rheumatology advances in practice · 2024
Lire l'abstract Crossref ↓
Abstract Objectives PsA and gout are two prevalent rheumatic diseases, that can be associated as part of a rheumatism known as ‘Psout’. Both conditions are associated with cardiovascular (CV) risk, thus their co-occurrence could have significant implications for the management of CV risks and patient care. This study aimed to determine the prevalence of gout within a PsA patient cohort and, consequently, to identify factors associated with this pathological association. Methods This is an observational, descriptive, cross-sectional, single-center study, including patients diagnosed with PsA. Demographic, clinical, biological and imaging data were collected. We identified the proportion of patients simultaneously affected by PsA and gout and compared characteristics between those with and without gout. Results The prevalence of gout among PSA patients was 9.8% (12/122), with a prevalence of 23% for asymptomatic hyperuricemia and 7.4% presenting with specific US signs of gout. Significant associated factors in the univariate analysis included weight, hypertension, diabetes, certain medications (diuretics, aspirin, lipid-lowering agents), impaired renal function, elevated fasting blood glucose, lipid abnormalities and specific US signs of gout. Conclusion Our study has described the existence of patients simultaneously affected by PsA and gout (‘Psout’). Performing joint US along with uric acid level measurements in PsA patients can enable personalized therapeutic care.
Publications scientifiques (3) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
JAK inhibiteurs1
▼
JAK inhibiteurs1
▼- Therapeutic Maintenance of Baricitinib and Tofacitinib in Real Life
Journal of clinical medicine · 2020 · Journal Article
Deprez V, Le Monnier L, Sobhy-Danial JM, Grados F, et al.
📚 8 cit.
Lombalgie1
▼
Lombalgie1
▼- Lumbar zygapophyseal joints injections under ultrasound guidance an alternative to fluoroscopy guidance in the management of low back pain
Scientific reports · 2022 · Journal Article
Touboul E, Salomon-Goëb S, Boistelle M, Sobhy Danial J, et al.
📚 7 cit.🎯 RCR 1.06🩺 Clinique
Transversal1
▼
Transversal1
▼- Interest in daily clinical practice of screening for gouty disease in patients with psoriatic arthritis
Rheumatology advances in practice · 2024 · Journal Article
Moukarzel V, Doussière M, Barbier V, Menis J, et al.
📚 1 cit.
